InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Ralph Niven, CHIEF SCIENTIFIC OFFICER, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 16 open-market SEC Form 4 transactions: 0 purchases worth $0 and 16 sales worth $912K, reported from Aug 18, 22 to Feb 5, 24. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 5, 24 | AVTEAerovate Therapeutics, Inc. | SELL | 4.6K | $17.45 | $80K |
| Jan 5, 24 | AVTEAerovate Therapeutics, Inc. | SELL | 2.5K | $19.57 | $48K |
| Dec 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 4.6K | $16.30 | $75K |
| Nov 22, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 13.8K | $15.00 | $207K |
| Jul 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.0K | $17.87 | $35K |
| Jun 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $16.26 | $37K |
| May 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.0K | $21.63 | $43K |
| Apr 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 1.7K | $19.11 | $31K |
| Mar 6, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.2K | $24.92 | $52K |
| Feb 6, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $24.27 | $55K |
| Jan 5, 23 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $26.40 | $59K |
| Dec 5, 22 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $17.38 | $39K |
| Nov 7, 22 | AVTEAerovate Therapeutics, Inc. | SELL | 1.4K | $20.29 | $28K |
| Oct 5, 22 | AVTEAerovate Therapeutics, Inc. | SELL | 2.1K | $16.22 | $32K |
| Sep 6, 22 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $19.00 | $43K |
| Aug 18, 22 | AVTEAerovate Therapeutics, Inc. | SELL | 2.3K | $21.18 | $48K |